Article
Genetic lesions in diffuse large B-cell lymphomas.
Annals of oncology : official journal of the European Society for Medical Oncology - 1 Jun 2015
Testoni M, Zucca E, Young K H, Bertoni F
Abstract excerpt
Diffuse large B-cell lymphoma (DLBCL) is the most common lymphoma in adults, accounting for 35%-40% of all cases. The combination of the anti-CD20 monoclonal antibody rituximab with anthracycline-based combination chemotherapy (R-CHOP, rituximab with cyclophosphamide, doxorubicin, vincristine and prednisone) lead to complete remission in most and can cure more than half of patients with DLBCL. The diversity in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
